By Leslie Coplin, Executive Editor, AHC Media
Glioblastoma in the elderly has been considered a futile and untreatable disease, but a recent study shows that combined-modality therapy with radiation and chemotherapy is beneficial in this population.
Using data from the National Cancer Database, researchers at the University of Colorado School of Medicine conducted a retrospective cohort study of elderly patients age 65 years or older with newly diagnosed glioblastoma who received combined-modality therapy with both radiotherapy and chemotherapy, radiotherapy alone, or chemotherapy alone. The authors determined that the combined-modality treatment was superior to either treatment alone, thus opening this treatment to patients previously not eligible for the combined treatment.
The July issue of Neurology Alert will provide clinically relevant commentary on this important study.
“These results give hope to a population of patients whose treatment options previously were limited,” says Neurology Alert Editor Matthew E. Fink, MD.